Rizatriptan Benzoate Tablet
Product Images NDC 50090-3343

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 50090-3343). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500903343)

Rizatriptan Benzoate 10 mg oral tablet packaging label from A-S Medication Solutions, NDC 50090-3343. The label specifies that each tablet contains 14.3 mg of Rizatriptan Benzoate, USP, equivalent to 10 mg Rizatriptan and that the package contains 18 tablets. Storage instructions indicate keeping between 68 to 77 degrees Fahrenheit. Additional identifiers include the product number 6404-0 and the distributor's address in Libertyville, IL.*

FDA Label Image

Rizatriptan Fig 1

A line graph showing the estimated probability of response over time in hours post-dose for Rizatriptan Benzoate 5 mg, Rizatriptan Benzoate 10 mg, and placebo. The graph illustrates increasing response rates for both doses of Rizatriptan Benzoate compared to placebo, with the 10 mg dose showing the highest response probability up to 2 hours post-dose.*

FDA Label Image

Rizatriptan Fig 2

A line graph depicting estimated probability of medication or rescue over 24 hours post-dose for placebo and Rizatriptan Benzoate 5 mg and 10 mg doses. The x-axis shows hours post-dose from 0 to 24, and the y-axis shows probability percentage from 0% to 100%, illustrating differences in response between placebo and active doses over time.*

FDA Label Image

Rizatriptan Fig 5

A line graph comparing the percentage response over time post second dose between Rizatriptan Benzoate and placebo. The x-axis represents hours post second dose, ranging from 0.5 to 2.0 hours, and the y-axis shows percentage response with confidence intervals. Rizatriptan Benzoate consistently shows higher response percentages than placebo at each time point.*

FDA Label Image

Rizatriptan Structure

Chemical structure of Rizatriptan Benzoate showing the molecular arrangement of the Rizatriptan moiety combined with the benzoate group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.